Skip to content

Clinical trials

Essential Hypertension trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20092
20101
20111
20141
20161
20183
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daiichi Sankyo3
ReCor Medical, Inc.2
University Ghent2
Ablative Solutions, Inc.1
Bayer1
Novartis1
Novartis Pharmaceuticals1
Orchestra BioMed, Inc1
Sankyo Pharma Gmbh1
sigma-tau i.f.r. S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension14
Hypertension8
Vascular Diseases2
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Diabetic Angiopathies1
Isolated Systolic Hypertension1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.